Detalhe da pesquisa
1.
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer.
EMBO J
; 43(5): 780-805, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38316991
2.
Centriolar distal appendages activate the centrosome-PIDDosome-p53 signalling axis via ANKRD26.
EMBO J
; 40(4): e104844, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33350486
3.
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages.
Int J Mol Sci
; 23(6)2022 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35328442
4.
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
Nature
; 526(7572): 212-7, 2015 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26416734
5.
The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists.
J Gen Virol
; 100(2): 278-288, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30566072
6.
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.
Proc Natl Acad Sci U S A
; 113(46): 13197-13202, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27803322
7.
SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.
J Biol Chem
; 292(14): 6014-6026, 2017 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28179429
8.
The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.
J Biol Chem
; 292(33): 13702-13713, 2017 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28659343
9.
Galanin pathogenic mutations in temporal lobe epilepsy.
Hum Mol Genet
; 24(11): 3082-91, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25691535
10.
The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
J Virol
; 90(23): 10915-10927, 2016 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27681140
11.
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration.
PLoS Pathog
; 11(7): e1005050, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26181333
12.
TRIM5 is an innate immune sensor for the retrovirus capsid lattice.
Nature
; 472(7343): 361-5, 2011 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21512573
13.
Correction: The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.
J Biol Chem
; 294(49): 18951, 2019 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811051
14.
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.
PLoS Pathog
; 7(12): e1002442, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22194689
15.
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.
Proc Natl Acad Sci U S A
; 107(20): 9364-9, 2010 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20439730
16.
A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation.
Viruses
; 15(3)2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992361
17.
Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sample.
BMJ Open
; 13(6): e072650, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290944
18.
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine.
Res Sq
; 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292970
19.
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.
Vaccines (Basel)
; 11(10)2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37896949
20.
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals.
EBioMedicine
; 77: 103888, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196644